Shares of Teleflex Incorporated (NYSE:TFX – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twelve research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $147.70.
A number of research firms recently issued reports on TFX. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a report on Monday, April 13th. UBS Group began coverage on shares of Teleflex in a research report on Tuesday. They issued a “neutral” rating and a $145.00 price objective for the company. Wall Street Zen upgraded shares of Teleflex from a “sell” rating to a “hold” rating in a research report on Saturday, June 27th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Finally, BMO Capital Markets assumed coverage on shares of Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 target price on the stock.
Get Our Latest Analysis on Teleflex
Hedge Funds Weigh In On Teleflex
Teleflex Stock Up 0.2%
Shares of TFX opened at $134.50 on Thursday. Teleflex has a 52 week low of $100.18 and a 52 week high of $139.67. The firm has a market capitalization of $5.95 billion, a P/E ratio of -5.90, a P/E/G ratio of 1.00 and a beta of 0.82. The company has a 50-day simple moving average of $130.87 and a 200-day simple moving average of $121.12. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter last year, the company earned $1.44 earnings per share. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts expect that Teleflex will post 6.7 earnings per share for the current year.
Teleflex Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is -5.96%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Stories
- Five stocks we like better than Teleflex
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
